COVID-19 vaccine breakthrough infection among fully vaccinated healthcare workers in Duhok governorate, Iraqi Kurdistan: A retrospective cohort studyArticle Published on 2022-11-012022-11-16 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 변종, [키워드] association Break through infections Breakthrough infection COVID-19 COVID-19 vaccine dentist determine Duhok effective Effectiveness enrolled females fill out fully vaccination HCW HCWs healthcare healthcare worker Healthcare workers highest incidence Infection infections Iraqi Kurdistan majority male Mild moderate MOST multicenter omicron outcomes paramedics participant Pfizer polymerase chain positive postvaccination prevaccination questionnaire random respiratory retrospective cohort study risk factor SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 variant severity significantly the disease the vaccine Vaccine vaccine effectiveness variant was performed [DOI] 10.1002/jmv.27985 PMC 바로가기
Evaluation of the efficacy of four anti-SARS-CoV-2 antibodies after vaccination using kits from two manufacturers: A prospective, longitudinal, cohort study at 11 serial time points within 160 daysArticle Published on 2022-11-012022-11-15 Journal: International immunopharmacology [Category] SARS, 진단, 치료기술, [키워드] Accuracy acute respiratory syndrome Affect anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody antibodies antibody Antibody detection cohort study Consistency CoronaVac coronavirus COVID-19 Efficacy evaluated half-live IgG antibody IgM antibody immune response less moderate Neutralizing antibodies neutralizing antibody SARS-CoV-2 SARS-CoV-2 vaccines subject the vaccine total antibodies total antibody vaccination Vaccine [DOI] 10.1016/j.intimp.2022.109285 PMC 바로가기
An outlook on potential protein targets of COVID-19 as a druggable siteArticle Published on 2022-11-012022-11-15 Journal: Molecular biology reports [Category] COVID19(2023년), SARS, 변종, 치료제, [키워드] approved cause claimed clinical trial combating contagious COVID-19 COVID-19 disease Cryo-electron microscopy Delta Efficacy feature genomic help host cell host protein infecting inhibit mechanism of action MERS-CoV Mutation non-structural proteins omicron pandemic Protein Protein target proteolytic cleavage raised Repurposed drug required SARS-CoV SARS-CoV-2 SARS-CoV-2 entry SARS-CoV-2 protein shown similarity spike Spike protein strain suggested the vaccine therapeutic drugs therapeutic interventions Vaccines variants of SARS-CoV-2 viral infection virus Wuhan X-ray diffraction [DOI] 10.1007/s11033-022-07724-3 PMC 바로가기
Immunogenicity of Third-dose BNT162b2 mRNA Vaccine Following Two Doses of ChAdOx1 in Health Care Workers: A Prospective Longitudinal StudyArticle Published on 2022-11-012022-11-16 Journal: Annals of laboratory medicine [Category] SARS, 변종, [키워드] acute respiratory syndrome analyzed anti-S antibody BNT162b2 BNT162b2 mRNA ChAdOx1 collected Concentration coronavirus Coronavirus disease-19 COVID-19 delta variant demonstrated dose doses Effectiveness Efficacy eight healthcare worker help immunogenicity longitudinal NAbs Neutralizing neutralizing antibody occurred omicron outbreak pandemic predicted produced Prospective PROTECT reached regimen risk second dose study period the vaccine Three-dose vaccination. university hospital vaccination vaccination rate variant variants of concern Wuhan-Hu-1 [DOI] 10.3343/alm.2022.42.6.688 PMC 바로가기
Immunogenicity and safety of two doses of SARS-CoV-2 mRNA vaccine in kidney transplant recipients with low-dose rituximabArticle Published on 2022-11-012022-11-15 Journal: International journal of urology : official journa [Category] COVID19(2023년), SARS, 진단, [키워드] acute respiratory syndrome affected antibody antigen-specific T cell baseline cellular response Control controls coronavirus coronavirus disease COVID-19 demonstrated Deterioration dose enrolled enzyme-linked immunospot enzyme-linked immunospot assay evaluated healthcare worker healthy control humoral immunogenicity kidney Kidney function kidney transplant recipient kidney transplant recipients Kidney transplantation lack low-dose mRNA mRNA vaccine multivariate regression analysis not affect not significantly different profiles rituximab SARS-CoV-2 Seroconversion seroconversion rate Spike protein systemic adverse event the vaccine treatment history vaccination Vaccine [DOI] 10.1111/iju.14978 PMC 바로가기
Severe immunosuppression is related to poorer immunogenicity to SARS-CoV-2 vaccines among people living with HIVArticle Published on 2022-11-012022-11-15 Journal: Clinical microbiology and infection : the official [Category] COVID19(2023년), SARS, 진단, [키워드] 95% CI Analysis Antibody Response CD4 CD4 cell CD4 count CD4 T-cell CD4 T-cell counts Cluster Complete COVID-19 vaccine COVID-19 vaccines determine dose evaluated Humoral response IgG IgG antibody immunization Immunosuppression impair individual log median mRNA multicentre neutralization Neutralizing antibodies Patient people living with HIV PLWH predictor Probability prospective cohort study quantitative determination receiving response to vaccination SARS-CoV-2 SARS-CoV-2 vaccine SARS-CoV-2 vaccines Seroconversion Specific the antibody response the vaccine vaccination Vaccine with HIV [DOI] 10.1016/j.cmi.2022.05.018 PMC 바로가기
Immunological responses following the third dose of the BNT162b2 SARS-CoV-2 vaccine among Japanese healthcare workersArticle Published on 2022-11-012022-11-15 Journal: Journal of infection and chemotherapy : official j [Category] COVID19(2023년), SARS, 진단, [키워드] age alcohol all age groups anti-RBD antibody antibody level antibody levels Antibody Response Antibody titer Asian baseline binding domain BNT162b2 BNT162b2 mRNA BNT162b2 vaccine Boosted vaccination booster dose booster vaccination conducted COVID-19 COVID-19 vaccine dose eight elevated Ethnic groups group healthcare worker Healthcare workers healthy IgG information investigated Japan Japanese median median titer of BNT162b2 participant Prevent provided RBD response SARS-CoV-2 vaccine second dose serum shown significant increase the vaccine university vaccination Welfare [DOI] 10.1016/j.jiac.2022.07.006 PMC 바로가기
Geographical distribution of SARS-CoV-2 amino acids mutations and the concomitant evolution of seven distinct clades in non-human hostsArticle Published on 2022-11-012022-11-16 Journal: Zoonoses and Public Health [Category] COVID19(2023년), SARS, 변종, [키워드] Amino acid analysed Analysis antigenicity clade Combination country Denmark distribution early stage Efficacy epidemiological Evolution exhibiting GISAID globe Host human SARS-CoV-2 indicate Latvia Local moderate MOST Mutation mutations Netherlands Non-human Non-human hosts ORF10 ORF3a pandemic pathogenicity Proteome evolution raised SARS-CoV-2 SARS-CoV-2 variant sequence Seven Surveillance sustained the SARS-CoV-2 genome the vaccine Transmissibility transmissions USA variant viral evolution Viral transmission viral variant Whole-genome sequence zoonotic zoonotic transmission [DOI] 10.1111/zph.12971 PMC 바로가기
Third dose of COVID-19 mRNA vaccine appears to overcome vaccine hyporesponsiveness in patients with cirrhosisArticle Published on 2022-11-012022-11-16 Journal: Journal of hepatology [Category] SARS, 변종, [키워드] 95% CI appear B.1.1.529 B.1.617.2 BNT BNT162b2 BNT162b2 mRNA booster booster dose chronic liver disease cirrhosis compensated Control control group COVD-19 COVID-19 COVID-19 in patient COVID-19 vaccines COVID-19-related death Critical dose doses General population greater hepatic decompensation hyporesponsiveness immune dysregulation liver magnitude moderate Moderate COVID-19 Moderna mRNA-1273 vaccine mRNA vaccine mRNA-1273 outcome overcome participant Patient Pfizer predominant receipt reduction in retrospective cohort study risk of infection Support symptomatic the vaccine Vaccine Vaccines variants veteran with COVID-19 [DOI] 10.1016/j.jhep.2022.07.036 PMC 바로가기
Change in willingness to COVID-19 vaccination in China: Two online surveys during the pandemicArticle Published on 2022-11-012022-11-16 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 변종, [키워드] acute respiratory syndrome analyses analyzed booster build change concern conducted confidence coronavirus coronavirus disease COVID-19 COVID-19 vaccination cross-sectional declined Effectiveness Efficacy Epidemic Factor immunization indicate investigated Modification Odds ratio pandemic propensity score matching PSM SARS-CoV-2 SARS-CoV-2 vaccine significant increase the SARS-CoV-2 the vaccine Treatment vaccination vaccination intention Vaccine Vaccine acceptance Vaccine confidence vaccine willingness variant were measured [DOI] 10.1002/jmv.28004 PMC 바로가기